These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1861555)

  • 21. von Willebrand factor and cardiovascular disease.
    Badimon L; Badimon JJ; Chesebro JH; Fuster V
    Thromb Haemost; 1993 Jul; 70(1):111-8. PubMed ID: 8236085
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of the von Willebrand factor with platelets and thrombosis.
    Perutelli P; Mori PG
    Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombosis and atherosclerosis--role of thrombus formation in atherogenesis and thrombosis of organ arteries].
    Tanaka K
    Nihon Ronen Igakkai Zasshi; 1983 May; 20(3):201-6. PubMed ID: 6684703
    [No Abstract]   [Full Text] [Related]  

  • 25. Dyslipoproteinemias in atherosclerosis, thrombosis and restenosis after coronary angioplasty.
    Myler RK; Ryan C; Dunlap R; Shaw RE; Bashour TT; Cumberland DC; Mooney MR
    J Invasive Cardiol; 1995 Mar; 7(2):33-46. PubMed ID: 10155712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.
    Ip JH; Fuster V; Badimon L; Badimon J; Taubman MB; Chesebro JH
    J Am Coll Cardiol; 1990 Jun; 15(7):1667-87. PubMed ID: 2188991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
    Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis in man: natural history and effects.
    Gresham GA
    Proc Nutr Soc; 1972 Dec; 31(3):303-5. PubMed ID: 4665806
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of the development of arteriosclerosis of the aorta and coronary arteries in thyreotoxicosis (pathologoanatomic morphometric study)].
    Zhdanov VS
    Kardiologiia; 1971 Jun; 11(6):58-64. PubMed ID: 5138684
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: Resistance to the development of spontaneous atherosclerosis in pigs with von Willebrand's disease.
    Bowie EJ; Fuster V; Owen CA; Brown AL
    Thromb Diath Haemorrh; 1975 Nov; 34(2):599. PubMed ID: 1081750
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.
    Nichols TC; Samama CM; Bellinger DA; Roussi J; Reddick RL; Bonneau M; Read MS; Bailliart O; Koch GG; Vaiman M
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2455-9. PubMed ID: 7708664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of von Willebrand factor for the onset of arterial thrombosis.
    Goto S
    Clin Lab; 2001; 47(7-8):327-34. PubMed ID: 11499793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
    Spiel AO; Gilbert JC; Jilma B
    Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherothrombosis in von Willebrand disease: an analysis of the literature and implications for clinical management.
    Franchini M; Coppola A
    Semin Thromb Hemost; 2012 Mar; 38(2):185-99. PubMed ID: 22422333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of the coagulation and fibrinolytic parameters as predictors for carotid atherosclerosis].
    Nomura E; Kohriyama T; Yamaguchi S; Kajikawa H; Nakamura S
    Rinsho Shinkeigaku; 1996 Jun; 36(6):741-5. PubMed ID: 8937194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis.
    Brinkhous KM; Reddick RL; Read MS; Nichols TC; Bellinger DA; Griggs TR
    Mayo Clin Proc; 1991 Jul; 66(7):733-42. PubMed ID: 2072761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases].
    Dulhoste MN; Bonnet J; Vergnes C; Choussat A; Bricaud H
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1875-8. PubMed ID: 2514640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.